Nucleic Acid Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid Drugs Overall Market Size
2.1 Global Nucleic Acid Drugs Market Size: 2022 VS 2028
2.2 Global Nucleic Acid Drugs Market Size, Prospects & Forecasts: 2022-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Nucleic Acid Drugs Players in Global Market
3.2 Global Companies Nucleic Acid Drugs Product & Technology
4 Players Profiles
4.1 Sarepta Therapeutics
4.1.1 Sarepta Therapeutics Corporate Summary
4.1.2 Sarepta Therapeutics Business Overview
4.1.3 Sarepta Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.1.4 Sarepta Therapeutics Nucleic Acid Drugs R&D, and Plans
4.2 Ionis Pharmaceuticals
4.2.1 Ionis Pharmaceuticals Corporate Summary
4.2.2 Ionis Pharmaceuticals Business Overview
4.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.2.4 Ionis Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.3 Alnylam
4.3.1 Alnylam Corporate Summary
4.3.2 Alnylam Business Overview
4.3.3 Alnylam Nucleic Acid Drugs Product Offerings & Technology
4.3.4 Alnylam Nucleic Acid Drugs R&D, and Plans
4.4 Mina Therapeutics
4.4.1 Mina Therapeutics Corporate Summary
4.4.2 Mina Therapeutics Business Overview
4.4.3 Mina Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.4.4 Mina Therapeutics Nucleic Acid Drugs R&D, and Plans
4.5 BioNTech
4.5.1 BioNTech Corporate Summary
4.5.2 BioNTech Business Overview
4.5.3 BioNTech Nucleic Acid Drugs Product Offerings & Technology
4.5.4 BioNTech Nucleic Acid Drugs R&D, and Plans
4.6 NeXstar Pharmaceuticals
4.6.1 NeXstar Pharmaceuticals Corporate Summary
4.6.2 NeXstar Pharmaceuticals Business Overview
4.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offerings & Technology
4.6.4 NeXstar Pharmaceuticals Nucleic Acid Drugs R&D, and Plans
4.7 Nippon Shinyaku
4.7.1 Nippon Shinyaku Corporate Summary
4.7.2 Nippon Shinyaku Business Overview
4.7.3 Nippon Shinyaku Nucleic Acid Drugs Product Offerings & Technology
4.7.4 Nippon Shinyaku Nucleic Acid Drugs R&D, and Plans
4.8 Moderna Therapeutics
4.8.1 Moderna Therapeutics Corporate Summary
4.8.2 Moderna Therapeutics Business Overview
4.8.3 Moderna Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.8.4 Moderna Therapeutics Nucleic Acid Drugs R&D, and Plans
4.9 CureVac
4.9.1 CureVac Corporate Summary
4.9.2 CureVac Business Overview
4.9.3 CureVac Nucleic Acid Drugs Product Offerings & Technology
4.9.4 CureVac Nucleic Acid Drugs R&D, and Plans
4.10 Regulus Therapeutics
4.10.1 Regulus Therapeutics Corporate Summary
4.10.2 Regulus Therapeutics Business Overview
4.10.3 Regulus Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.10.4 Regulus Therapeutics Nucleic Acid Drugs R&D, and Plans
4.11 Miragen Therapeutics
4.11.1 Miragen Therapeutics Corporate Summary
4.11.2 Miragen Therapeutics Business Overview
4.11.3 Miragen Therapeutics Nucleic Acid Drugs Product Offerings & Technology
4.11.4 Miragen Therapeutics Nucleic Acid Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Nucleic Acid Drugs Market Size, 2023 & 2028
5.2 By Region - Global Nucleic Acid Drugs Revenue, (2023-2028)
5.3 United States
5.3.1 Key Players of Nucleic Acid Drugs in United States
5.3.2 United States Nucleic Acid Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Nucleic Acid Drugs in Europe
5.4.2 Europe Nucleic Acid Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Nucleic Acid Drugs in China
5.5.2 China Nucleic Acid Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global Nucleic Acid Drugs Market Size Markets, 2023 & 2028
6.2 Antisense Nucleic Acid Drugs
6.3 siRNA Drugs
6.4 saRNA Drugs
6.5 miRNA Drugs
6.6 mRNA Drugs
6.7 other
7 Sights by Application
7.1 By Application - Global Nucleic Acid Drugs Market Size, 2023 & 2028
7.2 Genetic Disease
7.3 Cancer
7.4 Cardiovascular Diseases
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nucleic Acid Drugs Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid Drugs Market Drivers in Global Market
Table 3. Nucleic Acid Drugs Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid Drugs in Global Market
Table 5. Global Companies Nucleic Acid Drugs Product & Technology
Table 6. Sarepta Therapeutics Corporate Summary
Table 7. Sarepta Therapeutics Nucleic Acid Drugs Product Offerings
Table 8. Ionis Pharmaceuticals Corporate Summary
Table 9. Ionis Pharmaceuticals Nucleic Acid Drugs Product Offerings
Table 10. Alnylam Corporate Summary
Table 11. Alnylam Nucleic Acid Drugs Product Offerings
Table 12. Mina Therapeutics Corporate Summary
Table 13. Mina Therapeutics Nucleic Acid Drugs Product Offerings
Table 14. BioNTech Corporate Summary
Table 15. BioNTech Nucleic Acid Drugs Product Offerings
Table 16. NeXstar Pharmaceuticals Corporate Summary
Table 17. NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offerings
Table 18. Nippon Shinyaku Corporate Summary
Table 19. Nippon Shinyaku Nucleic Acid Drugs Product Offerings
Table 20. Moderna Therapeutics Corporate Summary
Table 21. Moderna Therapeutics Nucleic Acid Drugs Product Offerings
Table 22. CureVac Corporate Summary
Table 23. CureVac Nucleic Acid Drugs Product Offerings
Table 24. Regulus Therapeutics Corporate Summary
Table 25. Regulus Therapeutics Nucleic Acid Drugs Product Offerings
Table 26. Miragen Therapeutics Corporate Summary
Table 27. Miragen Therapeutics Nucleic Acid Drugs Product Offerings
Table 28. By Region? Global Nucleic Acid Drugs Revenue, (US$, Mn), 2023 & 2028
Table 29. By Region - Global Nucleic Acid Drugs Revenue, (US$, Mn), 2023-2028
Table 30. By Type ? Global Nucleic Acid Drugs Market Size, (US$, Mn), 2023 & 2028
Table 31. By Application? Global Nucleic Acid Drugs Market Size, (US$, Mn), 2023 & 2028
List of Figures
Figure 1. Nucleic Acid Drugs Segment by Type in 2021
Figure 2. Nucleic Acid Drugs Segment by Application in 2021
Figure 3. Global Nucleic Acid Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid Drugs Market Size: 2022 VS 2028 (US$, Mn)
Figure 6. Global Nucleic Acid Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Nucleic Acid Drugs Revenue Market Share, 2023-2028
Figure 8. By Type - Global Nucleic Acid Drugs Revenue Market Share, 2023-2028
Figure 9. By Application - Global Nucleic Acid Drugs Revenue Market Share, 2023-2028
Industry Market Size
